Advertisement Covers CROI 2017


Highlights From First Day of CROI 2017

February 14, 2017

This week, we're at the 2017 Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle sharing news and information about some of the important new HIV research findings and data being released. After the first full day of sessions, we held two Facebook Live sessions with senior federal HIV leaders to hear about what they saw as some of the key science highlights of the day.

First, we caught up with Dr. Carl Dieffenbach, Director of the Division of AIDS at NIH's National Institute of Allergy and Infectious Diseases (NIAID). Among the science highlights Carl pointed to were discussions of new technologies like gene editing and genomics being used to explore ways to tackle HIV and cancer. He also discussed how proven HIV prevention techniques are being applied to great effect at the community level in Uganda. To learn about these developments and more, watch his conversation with his colleague Anne Rancourt below or on the Facebook page.

We also spoke with CDC's Dr. Jonathan Mermin about some noteworthy new data about declining HIV infections in the United States that CDC shared at the conference. Dr. Mermin explained that annual HIV infections have declined 18% nationwide between 2008 and 2014. But that progress was not the same for all populations or areas of the country, he noted. Watch his conversation with Anne Rancourt below or on the Facebook page to learn more. Read about the CDC data in this post.

The annual CROI conference has assembled over 4,200 HIV researchers in Seattle this week. The basic, translational, and clinical scientists from 90 countries are sharing and discussing the latest studies, notable developments, and best research methods in the ongoing battle against HIV/AIDS and related infectious diseases. Visit the conference website for abstracts, session descriptions, webcasts, and other materials being released over the course of the coming week.

More Updates to Follow

Be sure to tune in to's Facebook page tomorrow, February 15, and Thursday, February 16, at 5:00 p.m. (ET)/2:00 p.m. PT) to hear additional daily CROI highlights from Dr. Dieffenbach. Or watch the recording of that update later in the day. And be sure to comment and share!

Related Stories

New HIV Infections Drop 18% in 6 Years
Two-Drug Regimen Shines in HIV Treatment Switch Study
Pharmacokinetics and Full Phase 2 Results for Bictegravir, a New Integrase Inhibitor

This article was provided by

No comments have been made.

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read's Comment Policy.)

Your Name:

Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:

Please note: Knowledge about HIV changes rapidly. Note the date of this summary's publication, and before treating patients or employing any therapies described in these materials, verify all information independently. If you are a patient, please consult a doctor or other medical professional before acting on any of the information presented in this summary. For a complete listing of our most recent conference coverage, click here.


The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.